R. Aniq Filali, M. Kassimi, R. Jabbouri, A. Naïtlho
Abstract:
In December 2019, a viral pneumonia caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), begins in Wuhan (China) and quickly spread around the world. Today more than 3.5 million people are infected. Even though the mortality rate is relatively low, a considerable number of patients die every day. It appears that the cytokine storm is one of the main causes of death in coronavirus disease 2019 (COVID-19), and that targeting the inflammation process would save the most severe patients.
Reference this Research Paper (copy & paste below code):
R. Aniq Filali, M. Kassimi, R. Jabbouri, A. Naïtlho
(2020); COVID19: Inflammatory biomarkers, predictors of severity?; International Journal of Scientific and Research Publications (IJSRP)
10(08) (ISSN: 2250-3153), DOI: http://dx.doi.org/10.29322/IJSRP.10.08.2020.p10444